GlassScriptPhysician profile
Michael J Lupi
NPI 1407822067
$1,079.27
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $999 · 2020: $60.00 · 2023: $20.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $688.00 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $63.23 | 2019 | |
| Pacira Therapeutics, INC. | $45.51 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.96 | 2019 | |
| Kaleo, INC. | $35.01 | 2019 | |
| Boston Scientific Corporation | $33.84 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Depuy Synthes Sales INC. | $26.84 | 2019 | |
| Lilly USA, LLC | $23.50 | 2019 | |
| Pfizer INC. | $18.02 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $16.78 | 2019 | |
| Daiichi Sankyo INC. | $16.68 | 2019 | |
| Mdd US Operations, LLC | $15.95 | 2019 | |
| Medtronic USA, INC. | $15.52 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.48 | 2019 | |
| Nevro Corp. | $13.11 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $12.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lupi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.